The virus was removed 24 hours later, and the cells were fed with doxycycline 1 μg/mL (Millipore Sigma ... to library preparation at the University of Wisconsin–Madison Biotechnology Center Gene ...

Granite Bio is ready to rock ‘n’ roll, unveiling with $100 million and hopes of shaping new antibody treatments targeting ...

received high-dose doxycycline (50 mg twice daily, 100 mg daily, or 100 mg twice daily). All patients received adjunctive treatment. The most common adjunctive treatments were intralesional ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where aTyr Pharma, Inc. (NASDAQ:ATYR) stands against other hot biotech stocks under $5.

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we are going to look at where BioNTech SE (NASDAQ:BNTX) stands against other ...

Shanghai-based VelaVigo has been busy. The biotech granted Avenzo Therapeutics ex-China rights to a Nectin4xTROP2 bispecific antibody-drug conjugate in November, netting up to $50 million in ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Mural Oncology is a biotechnology company that focuses on using its protein engineering platform to develop cytokine-based immunotherapies for cancer treatment. The company aims to deliver ...

The proposed transaction values VERAXA Biotech AG at USD 1.64 billion with expected gross cash proceeds up to USD 253 million held in trust by Voyager Acquisition Corp.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...